Natera (NTRA) Stock News — Real-Time Coverage

Recent NTRA News Headlines

Latest news coverage for NTRA aggregated from WSJ, Bloomberg, The New York Times, Financial Times, and Google News. Real-time updates, free and ad-free.

1. How FDA Breakthrough Status For Natera’s Multi‑Cancer Test (NTRA) Has Changed Its Investment StoryYahoo Finance · 2026-10-10
2. Natera (NTRA) Stock May Be 33% Below Fair Value Despite FDA Breakthrough NewsYahoo Finance · 2026-10-10
3. Natera (NTRA) Could Be 33% Undervalued Following FDA Breakthrough Device DesignationYahoo Finance · 2026-10-10
4. Why Natera (NTRA) Stock Is Up TodayBarchart.com · 2026-10-09
5. Natera: Priced To Perfection Amidst Rising Competitive Threats (NASDAQ:NTRA)Seeking Alpha · 2026-10-07
6. $1000 Invested In Natera 10 Years Ago Would Be Worth This Much TodayBenzinga · 2026-10-05
7. Natera CEO Steven Chapman sells $526k in common stockInvesting.com · 2026-10-03
8. Natera president Solomon Moshkevich sells $1.24m in sharesInvesting.com · 2026-10-03
9. $1000 Invested In Natera 5 Years Ago Would Be Worth This Much TodayBenzinga · 2026-09-28
10. Hewlett Packard, Natera, UnitedHealth Group: CNBC ‘Final Trades’ - UnitedHealth Group (NYSE:UNH)Benzinga · 2026-09-28
11. Natera director Sheena’s trusts dispose of $7.0m in NTRA stockInvesting.com · 2026-09-25
12. RBC Capital raises Natera stock price target on MRD testing growthInvesting.com · 2026-09-25
13. RBC Raises Price Target on Natera to $460 From $350, Keeps Outperform RatingYahoo Finance · 2026-09-25
14. Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDxYahoo Finance · 2026-09-23
15. Why Is Natera (NTRA) Stock Soaring TodayYahoo Finance · 2026-09-22

NTRA options: max pain, gamma exposure (GEX) & key levels · Search NTRA in the news archive · All tickers